DarioHealth (NASDAQ:DRIO) Stock Price Passes Below Two Hundred Day Moving Average – Here’s Why

DarioHealth Corp. (NASDAQ:DRIO)’s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.01 and traded as low as $0.72. DarioHealth shares last traded at $0.73, with a volume of 30,751 shares.

DarioHealth Price Performance

The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.32 and a current ratio of 1.57. The firm has a fifty day simple moving average of $0.88 and a 200 day simple moving average of $1.00. The company has a market capitalization of $24.95 million, a PE ratio of -0.78 and a beta of 1.47.

Hedge Funds Weigh In On DarioHealth

Institutional investors have recently made changes to their positions in the company. DLK Investment Management LLC lifted its stake in DarioHealth by 71.6% in the third quarter. DLK Investment Management LLC now owns 100,550 shares of the company’s stock worth $113,000 after acquiring an additional 41,943 shares during the period. Appian Way Asset Management LP lifted its position in shares of DarioHealth by 3.1% in the 2nd quarter. Appian Way Asset Management LP now owns 1,375,880 shares of the company’s stock worth $1,637,000 after purchasing an additional 41,738 shares during the period. Finally, XTX Topco Ltd lifted its position in shares of DarioHealth by 81.4% in the 3rd quarter. XTX Topco Ltd now owns 29,455 shares of the company’s stock worth $33,000 after purchasing an additional 13,219 shares during the period. Hedge funds and other institutional investors own 33.39% of the company’s stock.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.